Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
138,173,841
-
Shares change
-
+11,843,158
-
Total reported value, excl. options
-
$1,728,114,850
-
Value change
-
+$152,141,225
-
Put/Call ratio
-
82.97%
-
Number of buys
-
100
-
Number of sells
-
-67
-
Price
-
$12.51
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q2 2015
216 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2015.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 138,173,841 shares
.
Largest 10 shareholders include OPPENHEIMER FUNDS INC (26,000,000 shares), PRIMECAP MANAGEMENT CO/CA/ (19,706,886 shares), VANGUARD GROUP INC (9,942,273 shares), FIRST TRUST ADVISORS LP (9,726,344 shares), BlackRock Fund Advisors (9,288,975 shares), STATE STREET CORP (5,408,175 shares), Invesco Ltd. (4,032,435 shares), FEDERATED INVESTORS INC /PA/ (3,576,900 shares), BlackRock Institutional Trust Company, N.A. (3,215,004 shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (2,212,775 shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.